Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to
In recent years, the pharmacy profession has seen significant expansion in the range of medicines that pharmacists can administer by injection. The scope has broadened
The introduction of electronic prescriptions has improved patient accessibility to medication and reduced the administrative burden on pharmacies related to faxed or emailed prescriptions. Most
Meridian Lawyers has collaborated with PDL to prepare an article about professional boundaries and the types of conduct that are likely to be the subject
Off-label prescribing occurs when a medication is used for a purpose that is not approved by the Australian Therapeutic Goods Administration (TGA). It may involve
In recent weeks, the PDL Professional Officers have received a number of queries regarding pharmacists’ obligations and liability when dispensing Mounjaro® (tirzepatide). Tirzepatide is a
The PDL Professional Officers have been made aware of a situation where a person approaches dispensary staff and introduces themselves as a representative from a
The PDL Professional Officers confirm that Victorian pharmacists have been receiving notifications regarding lapses in compliance with SafeScript. PDL strongly recommends that pharmacists take the
Each year pharmacies routinely see an increase in demand for vaccination services as winter approaches. The recent surge in demand for pharmacist-administered vaccines has also
PDL would like to remind NSW-based pharmacists and pharmacy owners of the requirement to complete an S8 stock check during March. While most pharmacists are